SPYRE THERAPEUTICS, INC. Earnings Per Share (Basic)
SPYRE THERAPEUTICS, INC. (SYRE) reported Earnings Per Share (Basic) of $1.06 per share for the 3-month period ending 2024-09-30, per its 10-Q/A filed 2024-11-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2024-11-18
- SPYRE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2024-09-30 was $1.06, a 23.26% increase year-over-year.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2024-06-30 was $0.59, a 98.53% decline year-over-year.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2024-03-31 was $0.72.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2023-09-30 was $0.86.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was $13.76.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$24.86.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for fiscal 2021 was -$25.02.
- SPYRE THERAPEUTICS, INC. earnings per share, basic for fiscal 2020 was -$1.52.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $1.06 10-Q/A · filed 2024-11-18 | -$1.36 10-Q · filed 2024-11-07 | $2.39 10-Q/A · filed 2024-11-18 | -$3.43 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | $0.59 10-Q/A · filed 2024-11-18 | -$0.86 10-Q · filed 2024-08-07 | $1.31 10-Q/A · filed 2024-11-18 | -$2.02 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | $0.72 10-Q/A · filed 2024-11-18 | -$1.20 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | $13.76 10-K/A · filed 2024-11-18 | -$49.12 10-K · filed 2024-02-29 | ||||||
| 2023-09-30 | $0.86 10-Q/A · filed 2024-11-18 | -$9.34 10-Q · filed 2023-11-09 | $14.65 10-Q/A · filed 2024-11-18 | -$69.57 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $40.14 10-Q/A · filed 2024-11-18 | -$2.27 10-Q · filed 2023-08-11 | $51.26 10-Q/A · filed 2024-11-18 | -$2.48 10-Q · filed 2023-08-11 | ||||
| 2023-03-31 | -$4.89 10-Q · filed 2024-05-09 | -$0.20 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | -$24.86 10-K · filed 2024-02-29 | -$0.99 10-K · filed 2023-03-02 | ||||||
| 2022-09-30 | -$4.84 10-Q · filed 2023-11-09 | -$0.19 10-Q · filed 2022-11-03 | -$20.17 10-Q · filed 2023-11-09 | -$0.81 10-Q · filed 2022-11-03 | ||||
| 2022-06-30 | -$0.27 10-Q · filed 2023-08-11 | -$0.63 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | -$0.37 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$25.02 10-K · filed 2024-02-29 | -$1.00 10-K · filed 2023-03-02 | ||||||
| 2021-09-30 | -$0.31 10-Q · filed 2022-11-03 | -$0.69 10-Q · filed 2022-11-03 | ||||||
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-04 | -$0.38 10-Q · filed 2022-08-04 | ||||||
| 2020-12-31 | -$1.52 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |